Divis Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review

Divis Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Divis Laboratories Ltd (Divis) is a pharmaceutical company which manufactures a broad range Active Pharmaceutical Ingredients (APIs) and intermediates. The product portfolio of the company includes generic APIs, nutraceuticals and custom synthesis of APIs, intermediates and specialty ingredients. The company also exports APIs to several countries in Asia, Europe and America. It operates manufacturing plants in Hyderabad, Visakhapatnam, Kakinada, all located in India. Divis is headquartered in Hyderabad, Telangana, India.

Divis Laboratories Ltd Key Recent Developments

Apr 01,2020: Update from Divis Labs related to COVID-19: Operations, measures put in place, support to the nation
Mar 09,2020: Divis Laboratories commences commercial production at DCV-SEZ Unit
Feb 05,2020: Divis Labs earns a consolidated PAT of Rs.359 crores in Q3 of FY20
Jan 31,2020: Divi s Laboratories : US-FDA inspection of unit -II at village Chippada, Andhra Pradesh
Jan 04,2020: Divis Laboratories: Change in directorate

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company




Section 1 - About the Company
Divis Laboratories Ltd - Key Facts
Divis Laboratories Ltd - Key Employees
Divis Laboratories Ltd - Key Employee Biographies
Divis Laboratories Ltd - Major Products and Services
Divis Laboratories Ltd - History
Divis Laboratories Ltd - Company Statement
Divis Laboratories Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Divis Laboratories Ltd - Business Description
Divis Laboratories Ltd - SWOT Analysis
SWOT Analysis - Overview
Divis Laboratories Ltd - Strengths
Divis Laboratories Ltd - Weaknesses
Divis Laboratories Ltd - Opportunities
Divis Laboratories Ltd - Threats
Divis Laboratories Ltd - Key Competitors
Section 3 Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 Companys Lifesciences Financial Deals and Alliances
Divis Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Divis Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Divis Laboratories Ltd, Recent Deals Summary
Section 5 Companys Recent Developments
Apr 01, 2020: Update from Divis Labs related to COVID-19: Operations, measures put in place, support to the nation
Mar 09, 2020: Divis Laboratories commences commercial production at DCV-SEZ Unit
Feb 05, 2020: Divis Labs earns a consolidated PAT of Rs.359 crores in Q3 of FY20
Jan 31, 2020: Divi s Laboratories : US-FDA inspection of unit -II at village Chippada, Andhra Pradesh
Jan 04, 2020: Divis Laboratories: Change in directorate
Nov 15, 2019: Divis Laboratories: US-FDA Inspection of Unit -I at village Lingojigudem, Bhuvanagiri Yadadri District, Telangana
Nov 05, 2019: Divis Labs earns a PAT of Rs. 357 crores for Q2 of FY20 on consolidated basis
Aug 10, 2019: Divis Labs earns a total revenue of Rs. 1193 crores for Ql of FY20 on consolidated basis
May 25, 2019: Divis Labs earns a Revenue of Rs.5102 crores for FY19 on consolidated basis.
Mar 28, 2019: Divis Laboratories: Appointment of director
Section 6 Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables


Divis Laboratories Ltd, Key Facts
Divis Laboratories Ltd, Key Employees
Divis Laboratories Ltd, Key Employee Biographies
Divis Laboratories Ltd, Major Products and Services
Divis Laboratories Ltd, History
Divis Laboratories Ltd, Subsidiaries
Divis Laboratories Ltd, Key Competitors
Divis Laboratories Ltd, Ratios based on current share price
Divis Laboratories Ltd, Annual Ratios
Divis Laboratories Ltd, Annual Ratios (Cont...1)
Divis Laboratories Ltd, Annual Ratios (Cont...2)
Divis Laboratories Ltd, Interim Ratios
Divis Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Divis Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Divis Laboratories Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures


Divis Laboratories Ltd, Performance Chart (2016 - 2020)
Divis Laboratories Ltd, Ratio Charts
Divis Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Divis Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

Divis Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review

Divis Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Triumph Aerostructures - Vought Aircraft Division - Strategy, SWOT and Corporate Finance Report

Triumph Aerostructures - Vought Aircraft Division - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the companys structure, operation, SWOT

USD 175 View Report

Proteomics International Laboratories Ltd (PIQ) - Product Pipeline Analysis, 2020 Update

Proteomics International Laboratories Ltd (Proteomics) operates as a medical technology company that discovers new biopharmaceutical drugs. The company harnesses its proprietary proteomics-based technology platform to work in three integrated areas;

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available